close

LEUKAEMIA

In 2018, leukaemia incidence ranged between 8 cases per 100,000 inhabitants in Bulgaria to 20.4 in Lithuania.

LEUKAEMIA INCIDENCE

In 2018, leukaemia incidence ranged from 8 cases per 100,000 inhabitants in Bulgaria to 20.4 in Lithuania, with the EU28+EFTA average at 14.6.

.

.

.

.

Multiple myeloma Incidence - In 2018, multiple myeloma incidence ranged from 2.3 cases per 100,000 inhabitants in Bulgaria to 10.2 in Italy, with the EU28+EFTA average at 8.1.

.

.

.

Hodgkin’s Lymphoma Incidence - In 2018, Hodgkin’s lymphoma incidence ranged from 1.3 cases per 100,000 inhabitants in Romania to 6.6 in Greece, with the EU28+EFTA average at 2.7.

.

.

.




Non-Hodgkin’s Lymphoma Incidence - In 2018, Non-Hodgkin’s lymphoma incidence ranged from 7.3 cases per 100,000 inhabitants in Romania to 25.8 in Slovenia, with the EU28+EFTA average at 19.1.

LEUKAEMIA MORTALITY, 2018

In 2018, leukaemia mortality for women ranged from 3.6 cases per 100,000 inhabitants in Iceland to 10.8 in Estonia, with the EU28+EFTA average at 7.9. For men, it ranged from 6.5 in Iceland and 14.4 in Greece, with the EU28+EFTA average at 10.7.

.

.

.

.

Multiple myeloma mortality – In 2018, multiple myeloma mortality for females ranged from 1.6 cases per 100,000 inhabitants in Bulgaria to 6.8 in Portugal, with the EU28+EFTA average at 4.6. For males, it ranged from 1.7 in Bulgaria to 6.9 in the Netherlands and Italy, with the EU28+EFTA average at 5.5.

.

.

.

Hodgkin’s lymphoma mortality – In 2018, Hodgkin’s lymphoma mortality for females ranged from 0 cases per 100,000 inhabitants in Iceland, Luxembourg and Malta to 1.6 in Greece, with the EU28+EFTA average at 0.4. For males, it ranged from 0 in Iceland, Luxembourg and Malta to 2.2 in Greece, with the EU28+EFTA average at 0.6.

.

.

.

Non-Hodgkin’s lymphoma mortality - In 2018, Non-Hodgkin’s lymphoma mortality for females ranged from 3 cases per 100,000 inhabitants in Iceland to 16.1 in Slovenia, with the EU28+EFTA average at 6.7. For males, it ranged from 3.9 in Romania to 12.6 in Slovenia, with the EU28+EFTA average at 8.7.

LYMPHOID SURVIVAL

The 5-year age-standardized survival for lymphoid cancers between 2010 and 2014 ranged from 40.4% in Romania and 72% in Switzerland.

.
/